Exelixis

Exelixis is a genomics-based drug discovery company located in South San Francisco, Ca. It works on the development of anti-cancer therapies. Exelixis has several compounds in various stages of FDA approval and is listed on NASDAQ (EXEL).

Business

Founders

Corey S. Goodman

Corey Goodman is the President of Pfizer’s Biotherapeutics and Bioinnovation Center. He oversees this newly established entrepreneurial center which is...

Address

Exelixis Headquarters

210 East Grand Avenue
South San Francisco California 94083

Revenue:

Currency Amount Valid Date
  • 98,700,000
  • Dec 31, 2006

Operating income:

Currency Amount Valid Date
  • -110,700,000
  • Dec 31, 2006

Market capitalization:

Currency Amount Valid Date
  • 930,000,000
  • Dec 31, 2007

Number of employees:

number date
  • 651
  • 2007

Ticker symbol:

Stock exchange Ticker symbol
  • EXEL

Venture Investors:

top ↑

Organization

Board members:

top ↑ top ↑

We can also tell you Exelixis is a…

If you know more about Exelixis, you can add more facts here »

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Exelixis was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution